期刊文献+

重组腺病毒Ad-Endostatin载体构建与表达检测 被引量:1

Construction of Recombinant Adenovirus-endostatin Vector and Detection of Its Expression
下载PDF
导出
摘要 目的构建含有人内皮抑素(Endostatin)基因的重组腺病毒Ad-Endostatin,检测其转染HEK293细胞的表达。方法用RT-PCR扩增Endostatin基因,并将其克隆到pShuttle2载体,再将Endostatin基因克隆到腺病毒载体Adeno-X重组为Ad-Endostatin重组腺病毒,感染HEK293细胞使病毒扩增,然后纯化和滴定腺病毒,用Western blot法分析Ad-Endostatin感染HEK293细胞后Endostatin蛋白的表达。结果 PCR和测序方法证明重组腺病毒载体Ad-Enostatin被成功构建,能感染HEK293细胞,Western blot分析,细胞Endostatin蛋白高表达。感染HEK293细胞8d后,观察到细胞出现细胞病变效应现象。结论重组腺病毒内皮抑素载体Ad-Endostatin感染HEK293细胞后可有效表达Endostatin蛋白。 Objective To construct a recombinant adenovirus vector expressing human endostatin and to detect the expression of Ad-Endostatin in HEK293 ceils. Methods Endostatin gene was cloned into plasmid pShuttle2 vector and pAdeno-X vector. Recombinant pAd-Endostatin was tansformated into HEK293 cells and Ad-Endostatin viruses were obtained, purified and titered. Endostatin expression was analyzed by Western Blot. Results pAd-Endostatin was successfully constructed and verified by PCR and sequencing. Ad-Endostatin was reproduced and endostatin was highly expressed in HEK293 cells. 8 days after transfection, CPE could be observed in HEK293 ceils by microscope. Conclusion The recombinant plamid pAd-Endostatin with endostatin gene was constructed successfully. After HEK293 ceils are infected by AdEndo recombinant viruses, Endostatin can be expressed in the ceils.
作者 龙洪清
出处 《咸宁学院学报(医学版)》 2012年第2期96-98,共3页 Journal of Xianning Univarsity(medical Sciences)
关键词 内皮抑素 重组腺病毒载体 肿瘤 Endostatin Recombinant adenovirus vector Tumor
  • 相关文献

参考文献8

  • 1Oleilly MS, Boehm T, Shing Y, et al. Endostatin: an en- dogenous inhibitor of angiogenesis and tumor growth [ J ]. Ce11,1997,88(2) :277.
  • 2Folkman J. Tumor angiogenesis: therapeutic implications [J]. New Engl J Med,1971,285:1182.
  • 3Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [ J ]. Nature, 1997,390 (6658) :404.
  • 4Skovseth DK, Veuger M J, Sorensen DR, et al. Endostatin dramaticaUy inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo [J]. Blood,2005,105(3) :1044.
  • 5Velde EA, Reijerkerk A, Brandsma D, et al. Early en- dostatin treatment inhibits metastatic seeding of murine coloreetal cancer cells in the liver and their adhesion to endothelial ceils [J]. Br J Cancer,2005,92(4) :729.
  • 6杨志广,刘林林,苏清秀,杨艳明,邵国光.小鼠分泌型内皮抑素原核表达载体pFLAG-ssEndostatin的构建[J].中国实验诊断学,2010,14(3):378-380. 被引量:2
  • 7李苏,詹靖,廖海,管忠震.内皮抑素腺病毒注射液瘤内给药的吸收与排泄研究[J].中国临床药理学杂志,2010,26(4):243-247. 被引量:2
  • 8李勇,高慧棋,马铎,徐岩松,孙淑芳,杨志杰.放射性药物与Egr-Endostatin重组质粒的协同抑瘤作用[J].中国实验诊断学,2010,14(6):824-827. 被引量:1

二级参考文献16

  • 1刘璐,王自正,高宏,李旭东,尹其华,黄鹰.^(32)P-胶体局部给药治疗胰腺移植瘤及其在淋巴道的运转[J].中华核医学杂志,2003,23(6):334-336. 被引量:12
  • 2YANGWei LIXiu-yi.Anti-tumor effect of pEgr-interferon-γ-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism[J].Chinese Medical Journal,2005(4):296-301. 被引量:20
  • 3O' Reilly MS, Boehm T, Shing Y, et al. Endostalin: an endogenous inhibitor of angiogenesis and tumor growth[J]. Cell, 1997,88(2) :277.
  • 4Folkman J. Tumor angiogenesis: therapeutic implications [J]. N Engl J Med, 1971,285 (21) : 1182.
  • 5Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J]. Nature, 1997,390(6658) :404.
  • 6Sauter B V, Martinet O,Zhang WJ, et al. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases [J]. Proc Natl Acad Sci USA, 2000,97 ( 9 ) : 4802-4807.
  • 7Skovseth DK, Veuger M J, Sorensen DR, et al. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo [J]. Blood,2005,105(3):1044.
  • 8te Velde EA, Reijerkerk A, Brandsma D, et al. Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells [J]. Br J Cancer, 2005,92(4) : 729.
  • 9Shi H, Huang Y, Zhou H, et al. Nucleolin is a Receptor that Mediates Antiangio-genic and Anti-tumor Activity of Endostatin [J]. Blood, 2007,110 (8):2899.
  • 10Abdollahi A, Hlatky L, Huber PE. Endostatin: the logic of antiangiogenic therapy[ J]. Drug Resist Updat,2005 ; 8:59 -74.

共引文献2

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部